Meyka Pro banner
Albert David Limited

Albert David Limited (ALBERTDAVD.NS) Stock Overview

Explore Albert David Limited’s financial performance, market position, analyst ratings, and future outlook.

ALBERTDAVD.NSNSE
HealthcareDrug Manufacturers - Specialty & Generic
822.85
92.30(12.63%)
Indian Market opens in 36h 54m

Albert David Limited (ALBERTDAVD.NS)

Meyka AI Score

Z

Key Financials

Market Cap4.7B
P/E Ratio-314.06
EPS (TTM)$-2.62
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$602.47
3 Months$595.08
1 Year Target$1027.72

ALBERTDAVD.NS Stock Analysis & Investment Overview (NSE)

Our AI-powered analysis of Albert David Limited (NSE: ALBERTDAVD.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Albert David Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ALBERTDAVD.NS on the NSE shows an RSI of 83.47, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $1027.72 for the NSE listing.

Key metrics behind Albert David Limited's NSE-traded stock include a P/E ratio of -314.06 and a market capitalization of 4.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ALBERTDAVD.NS on the NSE.

Price Performance (NSE: ALBERTDAVD.NS)

1-Day Change
12.63%
5-Day Change
19.31%
1-Month Change
16.71%
3-Month Change
4.19%
6-Month Change
20.91%
Year-to-Date (YTD) Change
11.71%
1-Year Change
1.42%
3-Year Change
0.75%
5-Year Change
43.89%
All-Time (Max) Change
163.52%

Contact Information

91 33 2262 8436
Gillander House, Kolkata, WB, 700001

Company Facts

14,760 Employees
IPO DateJun 14, 2016
CountryIN
Actively Trading

Frequently Asked Questions